1. |
李勉珊, 吴久鸿, 张忆文. 莫西沙星治疗国内社区获得性肺炎的 Meta 分析. 实用药物与临床, 2011, 14(3): 203-206.
|
2. |
任静, 杨蒙蒙, 衡宇, 等. 替加环素对比左氧氟沙星治疗社区获得性肺炎疗效与安全性的 Meta 分析. 药物流行病学杂志, 2015, 24(10): 577-581.
|
3. |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016 年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
4. |
Pakhale S, Mulpuru S, Verheij TJ, et al. Antibiotics for community-acquired pneumonia in adult outpatients. Cochrane Database Syst Rev, 2014 (10): CD002109.
|
5. |
刘武胜, 李如梅, 宋志锋, 等. 国内莫西沙星治疗老年社区获得性肺炎的临床疗效的 meta 分析. 当代医学, 2017, 23(9): 8-10.
|
6. |
王晖, 田瑜, 耿男. 莫西沙星对比阿奇霉素治疗社区获得性肺炎有效性和安全性的系统评价. 甘肃科技, 2015, 31(22): 139-143, 133.
|
7. |
范红, 刘思彤, 童翔, 等. 呼吸喹诺酮类与 β-内酰胺类联合大环内酯类治疗非 ICU 住院社区获得性肺炎患者有效性和安全性的系统评价. 中国循证医学杂志, 2015, 15(7): 824-832.
|
8. |
An MM, Zou Z, Shen H, et al. Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents, 2010, 36(1): 58-65.
|
9. |
Maimon N, Nopmaneejumruslers C, Marras TK. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur Respir J, 2008, 31(5): 1068-1076.
|
10. |
Yuan X, Liang BB, Wang R, et al. Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials. J Chemother, 2012, 24(5): 257-267.
|
11. |
王明华, 贾雪冬. 大环内酯与喹诺酮治疗社区获得性肺炎随机对照试验的 Meta 分析. 国外医药: 抗生素分册, 2013, 34(4): 161-164.
|
12. |
朱泓霞, 狄小园, 脱鸣富, 等. 单用氟喹诺酮类药物对比 β-内酰胺类联用大环内酯类药物治疗社区获得性肺炎的有效性和安全性的系统评价. 中国药房, 2013, 24(40): 3813-3816.
|
13. |
熊俊, 陈日新. 系统评价/Meta 分析方法学质量的评价工具 AMSTAR. 中国循证医学杂志, 2011, 11(9): 1084-1089.
|
14. |
Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ, 2005, 330(7489): 456.
|
15. |
Raz-Pasteur A, Shasha D, Paul M. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: systematic review and meta-analysis. Int J Antimicrob Agents, 2015, 46(3): 242-248.
|
16. |
Skalsky K, Yahav D, Lador A, et al. Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials. Clin Microbiol Infect, 2013, 19(4): 370-378.
|
17. |
Vardakas KZ, Siempos II, Grammatikos A, et al. Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. Can Med Assoc J, 2008, 179(12): 1269-1277.
|
18. |
Zhang L, Wang R, Matthew FE, et al. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials. Chin Med J (Engl), 2012, 125(4): 687-695.
|
19. |
范晓萍, 嵇宏亮, 留永咏. 莫西沙星序贯治疗社区获得性肺炎的 Meta 分析. 药物流行病学杂志, 2013, 22(6): 288-291.
|
20. |
王建波. 左氧氟沙星序贯疗法治疗社区获得性肺炎的 Meta 分析. 中华全科医学, 2014, 12(10): 1642-1644.
|